how to choose between semaglutide and tirzepatide 🚨 Trying Tirzepatide? ​ ​ Both work, but one may fit your goals better depending on your appetite, blood sugar, and metabolism. 🩵 ​ ​ 👉 If tirzepatide and semaglutide versus for

The question behind the question is usually: "How much longer will I be able to get compounded semaglutide at this price?" The pattern we see: patients conflate three separate timelines: Patent expiration (2031-2033 for the formulations that matter) FDA shortage list removal (expected late 2026 to Q1 2027) Generic market entry (2027 for oral, 2031-2032 for injectable, assuming no patent challenges) The timeline that affects current compounded access is number 2, not number 1

MCAS is fundamentally a condition of inappropriate mast cell activation with little to no neoplastic proliferation, distinguished from mastocytosis

9,29 MISCELLANEOUS Other therapies have been approved for the treatment of type 2 diabetes, but are less widely used and are not included in the 2014 ADA treatment algorithm

This pairing can lower HbA1c and reduce your risk of type 2 diabetes complications